The UK charity for Waldenstrom’s macroglobulinaemia – a rare type of blood cancer
Support Line: 0300 373 8500

Research Committee

WMUK’s research committee’s role is to evaluate whether a proposed project is consistent with the charity’s mission, whether the appropriate resources are in place to conduct the research and whether the study outcomes are likely to be useful. They also have responsibility to develop, implement and monitor the WMUK Research Strategy in accordance with WMUK’s strategic plan.

Jane Nicholson
WMUK's CEO
Jane Nicholson​, is our Chief Executive Officer, overseeing the launch of several key initiatives at WMUK.
Dr Harriet Scorer
Harriet was diagnosed with WM over 20 years ago. She is a qualified doctor (gynaecology) and runs her own healthcare consultancy business.
Dr Dima-El-Sharkawi
Dr Dima El-Sharkawi Consultant Haematologist MB BS MA PhD MRCP FRCPath
Dr Roger Owen
Dr Roger Owen is a leading consultant in clinical haematology and haematopathology, specialising in Waldenström’s macroglobulinaemia.
Joy Ellery
Joy Ellery is a Patient Safety Partner at The Royal Marsden Hospital and sits on the WMUK Research Committee.
Professor Sam Salek
Professor Sam Salek is the Director at the Institute for Medicine Development in Cardiff, and a Professor of Pharmacoepidemiology at the School of Life and Medical Sciences, where he leads the Public Health & Patient Safety research group.
Dr Karen Facey
Dr. Karen Facey is a Chartered Statistician and an Honorary Member of the Faculty of Public Health. She works internationally as an Evidence-Based Health Policy Consultant, specialising in health technology assessment (HTA).